Kayne Anderson Rudnick Investment Management, LLC 13D/13G Filings for Anika Therapeutics, Inc. (ANIK)

Kayne Anderson Rudnick Investment Management, LLC 13D and 13G filings for Anika Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2022-06-09
4:15 pm
Sale
2022-05-3113GANIKA THERAPEUTICS INC
ANIK
Kayne Anderson Rudnick Investment Management, LLC627,321
4.310%
-840,189decrease
(-57.25%)
Filing
2022-02-11
6:27 pm
Sale
2021-12-3113GANIKA THERAPEUTICS INC
ANIK
Kayne Anderson Rudnick Investment Management, LLC1,467,510
10.170%
-78,753decrease
(-5.09%)
Filing